| abstract |
The invention relates to novel substituted prolinamides of general formula (I), wherein D, L, E, G, J, M, R3, R4, R5 and R13 are defined as in the description, the tautomers, enantiomers, diastereomers, mixtures and salts thereof, especially the physiologically acceptable salts thereof with inorganic or organic acids or bases. The prolinamides according to the invention have valuable properties. |